Our results showed that Stattic selectively inactivated STAT3 by inhibiting STAT3Y705 phosphorylation in PANC-1 cells, but not in BxPc-3 cells, suggesting the difference in anti-tumor mechanism of Stattic in different PCCs. This evidence concerns the gene STAT3 and neoplasm.